The Ministry of Health will inspect in 6 days.

An authorized source of the Government Inspectorate (GIG) said that as scheduled, on September 15, the GIG will announce the inspection decision at the Ministry of Health. The announcement will take place at the headquarters of the Ministry of Health.

"This is a planned inspection, the inspection content is investment projects at the Ministry of Health" - the source said.

Responding to the question of whether this inspection includes the inspection of drug import licensing, drug circulation registration and drug supply bidding of VN Pharma Joint Stock Company, the source said "no".

Continuing to ask after the Prime Minister's directive, did the Government Inspectorate have a plan to inspect the contents related to VN Pharma? This person also said "not yet".

Previously, on September 7, the Government Office issued a document conveying the direction of Prime Minister Nguyen Xuan Phuc requesting an inspection of the licensing of drug imports, the granting of drug circulation registration certificates, and the winning of drug supply bids by VN Pharma Joint Stock Company.

The document stated that recently, some mass media have published articles about the case that occurred at VN Pharma Joint Stock Company, reflecting on the lax management in granting import licenses and drug registration by the Ministry of Health; The Ministry of Health issued Document No. 949/BC-BYT dated August 29 reporting on the state management responsibility of the Ministry of Health in the case of VN Pharma Joint Stock Company.

Regarding this matter, the Prime Minister requested the Government Inspectorate to conduct an inspection of the licensing of drug imports and the issuance of drug circulation registration certificates for seven types of drugs produced by Helix Pharmaceuticals Inc., Canada, and the winning of drug supply packages for hospitals by VN Pharma JSC before the incident occurred; and report to the Prime Minister before December 31.

As reported by Ho Chi Minh City Law, many experts and National Assembly members have spoken out to request clarification of all hidden aspects of the licensing of the import of the H-Capita cancer drug batch at VN Pharma company and the Ministry of Health's claim that this is a poor quality drug, not a fake drug.

At the Government press conference on August 30, Deputy Minister of Health Nguyen Viet Tien said that based on the 2005 Pharmacy Law (clauses 23 and 24, Article 2) and the appraisal results of the Ministry of Health's appraisal council, this batch of H-Capita medicine is only a poor quality medicine, not a fake medicine.

However, many experts in the fields of medicine, anti-smuggling, counterfeit goods and legal experts believe that there are grounds to believe that the above batch of H-Capita medicine is counterfeit when the conclusion of the investigation agency and the appraisal council clearly states that this batch of medicine has unknown origin and source and this is a medicine that cannot be used as medicine for humans.

VN Pharma's actions show signs of constituting the crime of manufacturing and trading in counterfeit goods as prescribed in Article 156 of the 1999 Penal Code (amended and supplemented in 2009).

The case is currently being reviewed by the High People's Procuracy in Ho Chi Minh City to clarify related procedural issues.

According to PLO